Veristat Expands Its Clinical Operations into Europe - Acquires UK-based CRO, Spero Oncology
SOUTHBOROUGH, MA – May 2, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its...
SOUTHBOROUGH, MA – May 2, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its...
Veristat, a full service Clinical Research...
Veristat joins the Boston Business Journal’s 2016 Fast 50 (Formerly Pacesetters) list. This is the list of the fastest growing private...
SOUTHBOROUGH, MA – March 08, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today the appointment of Faith...
Veristat Raises over $20,000 to Support Rare Cancer Research
On Saturday, February 27th, Team Veristat JOINED THE BATTLE with Cycle for...
Veristat Supports the Upcoming Boston Cycle for Survival Event Join Veristat in the Fight Against Rare Cancers: Donate Today!
Veristat to Assist Cidara with Its Trials for Novel Echinocandin Antifungal CD101